chr1-63323453-C-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_012183.3(FOXD3):c.395C>A(p.Pro132Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000275 in 1,453,260 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_012183.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FOXD3 | NM_012183.3 | c.395C>A | p.Pro132Gln | missense_variant | 1/1 | ENST00000371116.4 | NP_036315.1 | |
FOXD3-AS1 | NR_121637.1 | n.87+902G>T | intron_variant, non_coding_transcript_variant | |||||
FOXD3-AS1 | NR_121636.1 | n.185+38G>T | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FOXD3 | ENST00000371116.4 | c.395C>A | p.Pro132Gln | missense_variant | 1/1 | NM_012183.3 | ENSP00000360157 | P1 | ||
FOXD3-AS1 | ENST00000427268.1 | n.87+902G>T | intron_variant, non_coding_transcript_variant | 1 | ||||||
FOXD3-AS1 | ENST00000431294.7 | n.286+38G>T | intron_variant, non_coding_transcript_variant | 1 | ||||||
FOXD3-AS1 | ENST00000697579.1 | n.203+20G>T | intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000275 AC: 4AN: 1453260Hom.: 0 Cov.: 34 AF XY: 0.00000138 AC XY: 1AN XY: 723042
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 26, 2022 | The c.395C>A (p.P132Q) alteration is located in exon 1 (coding exon 1) of the FOXD3 gene. This alteration results from a C to A substitution at nucleotide position 395, causing the proline (P) at amino acid position 132 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at